Real‐world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan

Publisher: John Wiley & Sons Inc

E-ISSN: 1440-1746|33|3|710-717

ISSN: 0815-9319

Source: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.33, Iss.3, 2018-03, pp. : 710-717

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract